Topic Editors

1. Harvard Medical School/BWH, Harvard University, Boston, MA 02115, USA​
2. Manipal Institute of Technology, Manipal University, Manipal, India
Dr. Liqin Chen
Department of Toxicology and Health Inspection and Quarantine, School of Public Health, Tianjin Medical University, Tianjin, China
Prof. Dr. Keshava Balakrishna
Manipal Institute of Technology, Manipal, India
Prof. Dr. Chiranjay Mukhopadhyay
Kasturba Medical College, Manipaldisabled, Manipal, India

Application of Chromatography for Point of Care Diagnosis of Noncommunicable Diseases

Abstract submission deadline
30 June 2025
Manuscript submission deadline
31 August 2025
Viewed by
2953

Topic Information

Dear Colleagues,

The diagnosis of non-communicable diseases typically involves a comprehensive approach that combines medical history, physical examination, laboratory tests, and imaging studies. Biomarker detection has emerged as a valuable diagnostic tool for specific diseases, but precise and rapid quantification of disease-specific biomarkers requires analytical methods that can enable fast sampling and preconcentration from sample matrices. Therefore, solid-phase extraction and micro-extraction techniques are gaining popularity in medical diagnosis due to their unique advantages, including integrated sampling, extraction, and analysis by GC-MS or LC-MS. This Special Issue focuses on the latest discoveries in the field of non-communicable disease diagnosis and aims to bring together clinical and primary researchers to submit interdisciplinary works on cutting-edge techniques, including sample preparation techniques and chromatography methods. The topic covers the latest progress in the development of point-of-care tests, molecular diagnostic tests, animal models for diseases, appropriate dosages and formulations, as well as artificial intelligence and machine learning predictive tools/models for the following diseases (but not limited to): 1. COPD 2. Stroke 3. Alzheimer's disease 4. Liver disease 5. Chronic kidney disease 6. Sickle cell disease/thalassemia 7. Cancer—breast, cervix, oral, and lung 8. Diabetes 9. Cardiovascular disease.

Dr. Chiranjit Ghosh
Dr. Liqin Chen
Prof. Dr. Keshava Balakrishna
Prof. Dr. Chiranjay Mukhopadhyay
Topic Editors

Keywords

  • diagnosis; breath
  • metabolites
  • biomarker
  • point-of-care
  • non-invasive
  • VOC
  • gas chromatography
  • liquid chromatography
  • solid phase extraction

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Analytica
analytica
- 1.8 2020 12.8 Days CHF 1000 Submit
Metabolites
metabolites
3.4 5.7 2011 13.9 Days CHF 2700 Submit
Separations
separations
2.5 3.0 2014 12.4 Days CHF 2600 Submit
Toxins
toxins
3.9 7.5 2009 18.9 Days CHF 2700 Submit
Molecules
molecules
4.2 7.4 1996 15.1 Days CHF 2700 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
20 pages, 3284 KiB  
Article
Screening and Application of DNA Aptamers for Heparin-Binding Protein
by Xi Zhou, Yingying Cao, Xiaocui Huang, Shuqian Qiu, Xinran Xiang, Huimin Niu, Li Chen, Shuiliang Wang, Zhenyu Lin and Shenghang Zhang
Molecules 2024, 29(8), 1717; https://doi.org/10.3390/molecules29081717 - 10 Apr 2024
Viewed by 1644
Abstract
Rapid detection of heparin-binding protein (HBP) is essential for timely intervention in sepsis cases. Current detection techniques are usually antibody-based immunological methods, which have certain problems, such as complexity and slow detection, and fall short in meeting the urgency of clinical needs. The [...] Read more.
Rapid detection of heparin-binding protein (HBP) is essential for timely intervention in sepsis cases. Current detection techniques are usually antibody-based immunological methods, which have certain problems, such as complexity and slow detection, and fall short in meeting the urgency of clinical needs. The application of an aptamer can address these concerns well. In this study, HBP-specific DNA aptamers were screened first. Among which, Apt-01, Apt−02, and Apt−13 had a high affinity for HBP, exhibiting impressive KD values of 3.42, 1.44, and 1.04 nmol/L, respectively. Then, the aptamer of HBP and its partially complementary primer probe were combined to form double-stranded DNA (dsDNA) and synthesize a circular DNA template. The template is complementary to the primer probe, but due to the presence of dsDNA, ExoIII cleaves C2-13 as an RCA primer probe, rendering the template unable to recognize the primer probe and preventing the RCA reaction from proceeding. When the target is present, it competes with the adapter for recognition and releases C2-13, exposing its 3′ end. After initiating the RCA at room temperature and reacting with SYBR GreenII at 37 °C for 20 min, fluorescence changes can be observed and quantitatively analyzed at a 530 nm wavelength, achieving quantitative biological analysis. Apt-01 was used to develop a fluorescent biosensor for HBP detection, which exhibited a good linear range (0.01 nmol/L to 10 nmol/L) and detection limit (0.0056 nmol/L). This advancement holds the potential to lay a solid groundwork for pioneering sensitive and specific methods for HBP detection and to significantly enhance the diagnostic processes for sepsis. Full article
Show Figures

Graphical abstract

Back to TopTop